Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 9:58 AM UTC
| NCT Number | NCT06562777 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | OHSU Knight Cancer Institute |
| Last Updated on CT.gov | September 8, 2026 (Sep 8, 2026) |
As of October 22, 2026: Clinical trial NCT06562777 is currently recruiting participants. This clinical trial study for hematopoietic and lymphatic system neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by OHSU Knight Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06562777 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06562777 was last updated Sep 8, 2026 (September 8, 2026). HelloStudys verifies this status automatically.